Cannell & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Cannell & Co's BSX Position: Q1 2022 in Review
Cannell & Co sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 14,852 shares — an estimated $631K sold.
Cannell & Co first reported a position in BSX in Q1 2018 and held it in 16 quarters. The position peaked at $55M in Q4 2019. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.
- Cannell & Co reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
- Cannell & Co sold 14,852 Boston Scientific shares in Q1 2022, an estimated $631K.
- Cannell & Co first reported a position in Boston Scientific in Q1 2018 and held it in 16 quarters.
- Cannell & Co's Boston Scientific position peaked at $55M in Q4 2019.
- 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.
Based on Cannell & Co's 13F filing for Q1 2022, filed 10 May 2022.